Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention. Insights Into the STRATEGY Study

Journal of the American College of Cardiology

Volumn 48, Issue 11, 2006, Pages 2178-2185

  Campo, Gianluca ^a   Valgimigli, Marco ^a,b,c   Gemmati, Donato ^a   Percoco, Gianfranco ^a   Tognazzo, Silvia ^a   Cicchitelli, Giordano ^a   Catozzi, Linda ^a   Malagutti, Patrizia ^a   Anselmi, Maurizio ^d   Vassanelli, Corrado ^d   Scapoli, Gianluigi ^a   Ferrari, Roberto ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b IRCCS   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Dipartimento di Scienze Biomediche e Chirurgiche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; RAPAMYCIN; TIROFIBAN;

ADULT; AGED; ANALYZER; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; DRUG MEGADOSE; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; CORONARY ANGIOGRAPHY; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS; STENTS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; TYROSINE;

EID: 33845297690     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.12.085     Document Type: Article

References (22)

1. Topol E.J., Neumann F.J., and Montalescot G. A preferred reperfusion strategy for acute myocardial infarction. J Am Coll Cardiol 42 (2003) 1886-1889
2. Antoniucci D., Rodriguez A., Hempel A., et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 42 (2003) 1875-1879
3. Kabbani S., Watkins M., Ashikaga T., et al. Platelet reactivity characterized prospectively. A determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104 (2001) 181-186
4. Frossard M., Fuchs I., Leitner J., et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 110 (2004) 1392-1397
5. Steinhubl S., Talley D., Braden G., et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention. Results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 103 (2001) 2572-2578
6. Valgimigli M., Percoco G., Malagutti P., et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 293 (2005) 2109-2117
7. Valgimigli M., Percoco G., Cicchitelli G., et al. High Dose Bolus Tirofiban and Sirolimus Eluting Stent Versus Abciximab and Bare Metal Stent in Acute Myocardial Infarction (STRATEGY) study-protocol design and demography of the first 100 patients. Cardiovasc Drugs Ther 18 (2004) 225-230
8. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
9. Gibson C.M., Cannon C.P., Daley W.L., et al. The TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
10. Van't Hof A., Liem A., Suryapranata H., et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction; myocardial blush grade. Circulation 97 (1998) 2302-2306
11. Mammen E.F., Comp P.C., Gosselin R., et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 24 (1998) 195-202
12. Madan M., Berkowitz S.D., Christie D.J., et al. Rapid assessment of glycoprotein IIb/IIIa blockade using the Platelet Function Analyzer (PFA-100) during percutaneous coronary interventions. Am Heart J 141 (2001) 226-233
13. Madan M., Berkowitz S.D., Christie D.J., et al. Determination of platelet aggregation inhibition during percutaneous coronary intervention with the Platelet Function Analyzer PFA-100. Am Heart J 144 (2002) 151-158
14. EPISTENT Investigators. Randomized placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 352 (1998) 87-92
15. Boersma E., Harrington R.A., Moliterno D.J., et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 359 (2002) 189-198
16. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., et al. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 115 (2005) 101-108
17. Gurbel P., Bliden K., Hiatt B., and O'Connor B. Clopidogrel for coronary stenting response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107 (2003) 2908-2913
18. Ajzenberg N., Aubry P., Huisse M.-G., et al. Enhanced shear-induced platelet aggregation in patients who experienced subacute stent thrombosis: a case-control study. J Am Coll Cardiol 45 (2005) 1753-1756
19. Wenaweser P., Dörffler-Melly J., Imboden K., et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45 (2005) 1748-1752
20. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54 (2005) 2430-2435
21. Morishima I., Sone T., Okumura K., et al. Angiographic no-reflow phenomen as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000) 1202-1209
22. Gurbel P.A., Bliden K.P., Guyer K., et al. Platelet reactivity in patients and recurrent events post-stenting. J Am Coll Cardiol 46 (2005) 1820-1826